Citations as recorded by:

1. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products

Biochemical and Biophysical Research Communications, 2017, 482(4) p. 1413

DOI: 10.1016/j.bbrc.2016.12.050

Citations as recorded by: Cross Ref Google

2. Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats

Med Sci Monit, 2017, 23 p. 4334

DOI: 10.12659/MSM.903252

Citations as recorded by: PMC Google

3. Advanced Glycation End Products Inhibit the Proliferation of Human Umbilical Vein Endothelial Cells by Inhibiting Cathepsin D

IJMS, 2017, 18(2) p. 436

DOI: 10.3390/ijms18020436

Citations as recorded by: Cross Ref PMC Google

4. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases

Vascular Pharmacology,

DOI: 10.1016/j.vph.2017.05.005

Citations as recorded by: Cross Ref Google

5. Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease

Neuropharmacology,

DOI: 10.1016/j.neuropharm.2017.09.023

Citations as recorded by: Cross Ref

6. Advanced glycation end products influence mitochondrial fusion-fission dynamics through RAGE in human aortic endothelial cells

Year: 2017

Citations as recorded by: Google

7. Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway

38(4) p. 1161

DOI: 10.3892/ijmm.2016.2711

Citations as recorded by: Cross Ref PMC

8. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

Drug Discovery Today, 2016, 21(5) p. 802

DOI: 10.1016/j.drudis.2016.01.013

Citations as recorded by: Cross Ref Google

9. Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway

13(2) p. 1593

DOI: 10.3892/mmr.2015.4724

Citations as recorded by: Cross Ref PMC

10. iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells

Pharmacological Research, 2016, 104 p. 176

DOI: 10.1016/j.phrs.2015.12.015

Citations as recorded by: Cross Ref

11. Glucagon‑like peptide‑1 protects cardiomyocytes from advanced oxidation protein product‑induced apoptosis via the PI3K/Akt/Bad signaling pathway

Year: 2016

Citations as recorded by: Google

12. iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth …

Year: 2016

Citations as recorded by: Google

13. Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE …

Year: 2016

Citations as recorded by: Google

14. p38MAPK/eNOS 信号通道在胰高血糖素样肽-1 抑制 AGEs 诱导的人脐静脉内皮细胞凋亡中的作用

Year: 2016

Citations as recorded by: Google

15. RAGE comme nouvelle cible thérapeutique prévenant le stress du réticulum endoplasmique et l'apoptose des cellules du muscle lisse vasculaire associés avec …

Year: 2016

Citations as recorded by: Google

16. AGEs 对人主动脉内皮细胞线粒体融合蛋白表达的影响

Year: 2016

Citations as recorded by: Google

17. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells

Endocrine, 2015, 50(3) p. 537

DOI: 10.1007/s12020-015-0709-4

Citations as recorded by: Google

18. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications

Cardiovasc Diabetol, 2015, 14

DOI: 10.1186/s12933-015-0176-5

Citations as recorded by: PMC

19. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular …

Year: 2015

Citations as recorded by: Google

20. GLP-1 通过 SDF-1/CXCR4 信号通路调控人脐血内皮祖细胞增殖, 分化和凋亡

Year: 2015

Citations as recorded by: Google

21. The possible link between high glucose-induced PKCβ expression and the appearance of GLP-1 resistance in endothelial cells

Year: 2015

Citations as recorded by: Google

22. Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals

Mediators of Inflammation, 2014, 2014 p. 1

DOI: 10.1155/2014/538737

Citations as recorded by: Cross Ref PMC Google

23. Toxic Effects of Levofloxacin on Rat Annulus Fibrosus Cells: An In-vitro Study

Med Sci Monit, 2014, 20 p. 2205

DOI: 10.12659/MSM.892610

Citations as recorded by: Google

24. GLP-1 ameliorates the proliferation activity of INS-1 cells inhibited by intermittent high glucose concentrations through the regulation of cyclins

10(2) p. 683

DOI: 10.3892/mmr.2014.2265

Citations as recorded by: Cross Ref Google

25. On anti-diabetic agents and the vasculature

Year: 2014

Citations as recorded by: Google

26. Advanced Glycation End Products Induce Human Corneal Epithelial Cells Apoptosis through Generation of Reactive Oxygen Species and Activation of JNK and p38 MAPK Pathways

PLoS ONE, 2013, 8(6) p. e66781

DOI: 10.1371/journal.pone.0066781

Citations as recorded by: Cross Ref PMC

27. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

J Diabetes Invest, 2013, 4(2) p. 108

DOI: 10.1111/jdi.12065

Citations as recorded by: Cross Ref PMC Google

28. An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes

Mediators Inflamm, 2013, 2013

DOI: 10.1155/2013/591056

Citations as recorded by: PMC Google

29. Incretin actions beyond the pancreas: lessons from knockout mice

Current Opinion in Pharmacology, 2013, 13(6) p. 946

DOI: 10.1016/j.coph.2013.09.013

Citations as recorded by: Cross Ref Google

30. Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and …

Year: 2013

Citations as recorded by: Google

31. Immune regulation in T1D and T2D: prospective role of Foxp3+ Treg cells in disease pathogenesis and treatment

Year: 2013

Citations as recorded by: Google

32. Końcowe produkty glikacji—nowy biomarker cukrzycy i jej powikłań?

Year: 2013

Citations as recorded by: Google

33. Incretin hormones as immunomodulators of atherosclerosis

Front Endocrinol (Lausanne), 2012, 3

DOI: 10.3389/fendo.2012.00112

Citations as recorded by: PMC Google